Pliant Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Pliant Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 84% to $1,580,000. Profit margin reached -10211%. Total operating expenses were $185,725,000.
Profit Margin
| 2017 | 0 | -20.62M | |
|---|---|---|---|
| 2018 | 0 | -30.27M | |
| 2019 | 57.05M | 185K | 0.32% |
| 2020 | 41.81M | -39.74M | -95.05% |
| 2021 | 7.57M | -17.90M | -236.49% |
| 2022 | 9.68M | -121.49M | -1254.5% |
| 2023 | 1.58M | -161.33M | -10211.14% |
PLRX Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 1.58M | 9.68M | 7.57M | 41.81M | 57.05M | 0 | 0 |
Cost of revenue | 0 | 3.68M | 3.20M | 0 | 0 | 0 | 0 |
Gross profit | 1.58M | 6.00M | 4.36M | 41.81M | 57.05M | 0 | 0 |
Operating exp. | |||||||
Research and development | 127.79M | 96.93M | 77.54M | 66.19M | 47.35M | 24.41M | 14.52M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 185.72M | 136.88M | 27.55M | 83.46M | 58.28M | 30.91M | 18.34M |
Operating income | -184.14M | -127.2M | -19.98M | -41.64M | -1.23M | -30.91M | -18.34M |
Other income (expenses), net | 22.80M | 3.87M | 272K | 112K | 600K | -49K | 16K |
Income before tax | -161.33M | -123.32M | -19.71M | -41.53M | -631K | -30.27M | -18.33M |
Income tax expense | 0 | -1.82M | -1.80M | -1.78M | -816K | 639K | 2.28M |
Net income | -161.33M | -121.49M | -17.90M | -39.74M | 185K | -30.27M | -20.62M |
Earnings per share | |||||||
Basic EPS | -2.75 | -2.89 | -0.5 | -1.12 | 0.00 | -1.83 | -25.67 |
Diluted EPS | -2.75 | -2.89 | -0.5 | -1.12 | 0.00 | -1.83 | -25.67 |
| Data source | Data source | Data source | Data source |